CLAY B. SIEGALL - 07 Jan 2022 Form 4 Insider Report for Seagen Inc.

Signature
By: /s/ Jennifer Prosba For: Clay B. Siegall
Issuer symbol
N/A
Transactions as of
07 Jan 2022
Net transactions value
-$2,021,895
Form type
4
Filing time
11 Jan 2022, 18:14:52 UTC
Previous filing
22 Dec 2021
Next filing
09 Feb 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGEN Common Stock Options Exercise $28,710 +1,100 +0.16% $26.10* 669,045 07 Jan 2022 Direct F1
transaction SGEN Common Stock Sale $161,876 -1,100 -0.16% $147.16 667,945 07 Jan 2022 Direct F1, F2, F3
transaction SGEN Common Stock Options Exercise $84,068 +3,221 +0.48% $26.10* 671,166 07 Jan 2022 Direct F1
transaction SGEN Common Stock Sale $469,751 -3,221 -0.48% $145.84 667,945 07 Jan 2022 Direct F1, F2, F4
transaction SGEN Common Stock Options Exercise $119,016 +4,560 +0.68% $26.10* 672,505 07 Jan 2022 Direct F1
transaction SGEN Common Stock Sale $660,379 -4,560 -0.68% $144.82 667,945 07 Jan 2022 Direct F1, F2, F5
transaction SGEN Common Stock Options Exercise $213,054 +8,163 +1.2% $26.10* 676,108 07 Jan 2022 Direct F1
transaction SGEN Common Stock Sale $1,174,737 -8,163 -1.2% $143.91 667,945 07 Jan 2022 Direct F1, F2, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SGEN Non-Qualified Stock Option (right to buy) Options Exercise $0 -1,100 -0.81% $0.000000 135,245 07 Jan 2022 Common Stock 1,100 $26.10 Direct F7
transaction SGEN Non-Qualified Stock Option (right to buy) Options Exercise $0 -3,221 -2.4% $0.000000 132,024 07 Jan 2022 Common Stock 3,221 $26.10 Direct F7
transaction SGEN Non-Qualified Stock Option (right to buy) Options Exercise $0 -4,560 -3.5% $0.000000 127,464 07 Jan 2022 Common Stock 4,560 $26.10 Direct F7
transaction SGEN Non-Qualified Stock Option (right to buy) Options Exercise $0 -8,163 -6.4% $0.000000 119,301 07 Jan 2022 Common Stock 8,163 $26.10 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F3 Reflects sales of common stock executed in multiple transactions at prices ranging from $146.71 to $147.68. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F4 Reflects sales of common stock executed in multiple transactions at prices ranging from $145.42 to $146.38. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F5 Reflects sales of common stock executed in multiple transactions at prices ranging from $144.41 to $145.36. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F6 Reflects sales of common stock executed in multiple transactions at prices ranging from $143.41 to $144.38. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F7 Options vested at a rate of 25% on 8/20/13 and monthly thereafter until all the options were fully vested on 8/20/16.